Literature DB >> 26754346

Parent-Reported Health Consequences and Relationship to Expenditures in Children with ADHD.

Neal A deJong1, Christianna S Williams2, Kathleen C Thomas2.   

Abstract

OBJECTIVES: (1) To describe parents' report of special needs for children with ADHD on the Children with Special Health Care Needs (CSHCN) Screener; and (2) to assess the association between responses to Screener items and annual mental health and total health expenditures per child.
METHODS: In pooled 2002-2011 Medical Expenditure Panel Survey (MEPS) data, we identify children ages 4-17 years with ADHD. We use OLS and two-part regressions to model the relationship between CSHCN Screener items and mental health and total health expenditures. Based on these models we estimate adjusted, average total health expenditures for children with ADHD-both with and without a co-morbid mental health condition-and different combinations of endorsed Screener items. This research was conducted in accordance with prevailing ethical principles.
RESULTS: There were 3883 observations on 2591 children with ADHD. Without a co-morbid mental health condition, average total expenditures per year from adjusted, model-based estimates were $865 for those meeting no Screener items, $2664 for those meeting only the medication item, $3595 for those meeting the medication and counseling items, and $4203 for those meeting the medication, counseling, and use of more health services items. Children with a co-morbid mental health condition had greater total health expenditures for each combination of Screener items. The associations between Screener items and mental health expenditures were similar, but with a slightly lower marginal effect of the medication item (p < 0.001 for all comparisons).
CONCLUSIONS: Parents' responses on the CSHCN Screener are associated with meaningful variation in expenditures for children with ADHD. Though cross-sectional, this study suggests that the CSHCN Screener can be a useful categorization scheme for children with ADHD. It may be an efficient, standardized tool at the point of care for identifying children who need more resources and for targeting intensive interventions in the context of population health management.

Entities:  

Keywords:  Attention deficit hyperactivity disorder (ADHD); CSHCN Screener; Children with Special Health Care Needs (CSHCN); Medical Expenditure Panel Survey (MEPS)

Mesh:

Year:  2016        PMID: 26754346     DOI: 10.1007/s10995-015-1880-1

Source DB:  PubMed          Journal:  Matern Child Health J        ISSN: 1092-7875


  19 in total

1.  Variability in ADHD care in community-based pediatrics.

Authors:  Jeffery N Epstein; Kelly J Kelleher; Rebecca Baum; William B Brinkman; James Peugh; William Gardner; Phil Lichtenstein; Joshua Langberg
Journal:  Pediatrics       Date:  2014-11-03       Impact factor: 7.124

2.  ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents.

Authors:  Mark Wolraich; Lawrence Brown; Ronald T Brown; George DuPaul; Marian Earls; Heidi M Feldman; Theodore G Ganiats; Beth Kaplanek; Bruce Meyer; James Perrin; Karen Pierce; Michael Reiff; Martin T Stein; Susanna Visser
Journal:  Pediatrics       Date:  2011-10-16       Impact factor: 7.124

3.  Use and costs of medical care for children and adolescents with and without attention-deficit/hyperactivity disorder.

Authors:  C L Leibson; S K Katusic; W J Barbaresi; J Ransom; P C O'Brien
Journal:  JAMA       Date:  2001-01-03       Impact factor: 56.272

4.  Prevalence and assessment of attention-deficit/hyperactivity disorder in primary care settings.

Authors:  R T Brown; W S Freeman; J M Perrin; M T Stein; R W Amler; H M Feldman; K Pierce; M L Wolraich
Journal:  Pediatrics       Date:  2001-03       Impact factor: 7.124

5.  Attention-deficit/hyperactivity disorder in children: excess costs before and after initial diagnosis and treatment cost differences by ethnicity.

Authors:  G Thomas Ray; Peter Levine; Lisa A Croen; Farasat A S Bokhari; Teh-Wei Hu; Laurel A Habel
Journal:  Arch Pediatr Adolesc Med       Date:  2006-10

6.  Identifying children with special health care needs: development and evaluation of a short screening instrument.

Authors:  Christina D Bethell; Debra Read; Ruth E K Stein; Stephen J Blumberg; Nora Wells; Paul W Newacheck
Journal:  Ambul Pediatr       Date:  2002 Jan-Feb

7.  Patterns and predictors of attention-deficit/hyperactivity disorder persistence into adulthood: results from the national comorbidity survey replication.

Authors:  Ronald C Kessler; Lenard A Adler; Russell Barkley; Joseph Biederman; C Keith Conners; Stephen V Faraone; Laurence L Greenhill; Savina Jaeger; Kristina Secnik; Thomas Spencer; T Bedirhan Ustün; Alan M Zaslavsky
Journal:  Biol Psychiatry       Date:  2005-06-01       Impact factor: 13.382

8.  Psychometric properties of the Vanderbilt ADHD diagnostic parent rating scale in a referred population.

Authors:  Mark L Wolraich; Warren Lambert; Melissa A Doffing; Leonard Bickman; Tonya Simmons; Kim Worley
Journal:  J Pediatr Psychol       Date:  2003-12

9.  Trends in the parent-report of health care provider-diagnosed and medicated attention-deficit/hyperactivity disorder: United States, 2003-2011.

Authors:  Susanna N Visser; Melissa L Danielson; Rebecca H Bitsko; Joseph R Holbrook; Michael D Kogan; Reem M Ghandour; Ruth Perou; Stephen J Blumberg
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2013-11-21       Impact factor: 8.829

10.  Collaborative care outcomes for pediatric behavioral health problems: a cluster randomized trial.

Authors:  David J Kolko; John Campo; Amy M Kilbourne; Jonathan Hart; Dara Sakolsky; Stephen Wisniewski
Journal:  Pediatrics       Date:  2014-03-24       Impact factor: 7.124

View more
  1 in total

1.  Treatment Patterns and Costs Among Children Aged 2 to 17 Years With ADHD in New York State Medicaid in 2013.

Authors:  Liqiong Guo; Melissa Danielson; Lindsay Cogan; Leah Hines; Brian Armour
Journal:  J Atten Disord       Date:  2018-12-14       Impact factor: 3.256

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.